The Data and Safety Monitoring Board and Acquired immune deficiency syndrome (AIDS) clinical trials-Reference-Cited by-同舟云学术

The Data and Safety Monitoring Board and Acquired immune deficiency syndrome (AIDS) clinical trials

Published:1995-12 Issue:6 Volume:16 Page:408-421
ISSN:0197-2456
Container-title:Controlled Clinical Trials
language:en
Short-container-title:Controlled Clinical Trials

Author:

DeMets David L.,Fleming Thomas R.,Whitley Richard J.,Childress James F.,Ellenberg Susan S.,Foulkes Mary,Mayer Kenneth H.,O'Fallon Judith,Pollard Richard B.,Rahal James J.,Sande Merle,Straus Stephen,Walters LeRoy,Whitley-Williams Patricia

Publisher

Elsevier BV

Subject

Pharmacology

Reference31 articles.

1. Organization, review and administration of cooperative studies (Greenberg Report): a report from the Heart Special Project Committee to the National Advisory Council, May 1967;Heart Special Project Committee;Controlled Clin Trials,1988

2. Data monitoring committees for multicenter clinical trials sponsored by the National Institutes of Health: I. Roles and membership of data monitoring committees for trials sponsored by the National Eye Institute;Hawkins;Controlled Clin Trials,1991

3. A case report of data monitoring experience: the Nocturnal Oxygen Therapy Trial;DeMets;Controlled Clin Trials,1982

4. Interim analysis in clinical trials;Armitage;Stat Med,1991

5. Proceedings of ‘Practical Issues in Data Monitoring of Clinical Trials’ Bethesda,1993

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials;The Journal of Infectious Diseases;2021-05-19

2. A joint industry‐sponsored data monitoring committee model for observational, retrospective drug safety studies in the real‐world setting;Pharmacoepidemiology and Drug Safety;2020-11-24

3. Achieving effective informed oversight by DMCs in COVID clinical trials;Journal of Clinical Epidemiology;2020-10

4. Data Monitoring Committee Meetings;Data Monitoring Committees in Clinical Trials;2019-02-01

5. Confidentiality Issues Relating to the Data Monitoring Committee;Data Monitoring Committees in Clinical Trials;2019-02-01